Innovent Biologics, Inc.
IVBXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$95 | -$1,144 | -$2,170 | -$2,729 |
| Dep. & Amort. | $420 | $385 | $319 | $205 |
| Deferred Tax | $0 | $0 | $0 | $50 |
| Stock-Based Comp. | $557 | $574 | $469 | $502 |
| Change in WC | $450 | $403 | $310 | -$90 |
| Other Non-Cash | -$44 | -$70 | -$847 | $37 |
| Operating Cash Flow | $1,287 | $148 | -$1,919 | -$2,025 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,119 | -$1,382 | -$1,848 |
| Net Acquisitions | $0 | $0 | $0 | -$630 |
| Inv. Purchases | $0 | -$9,414 | -$10,326 | -$10,338 |
| Inv. Sales/Matur. | $0 | $9,244 | $10,020 | $10,121 |
| Other Inv. Act. | -$1,165 | $291 | $252 | -$4 |
| Investing Cash Flow | -$1,165 | -$999 | -$1,435 | -$2,698 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$730 | $418 | $715 | $1,208 |
| Stock Issued | $84 | $2,255 | $2,131 | $3,951 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $39 | -$86 | $46 | -$155 |
| Financing Cash Flow | -$607 | $2,587 | $2,892 | $5,003 |
| Forex Effect | $13 | -$7 | $119 | -$197 |
| Net Chg. in Cash | -$472 | $1,730 | -$343 | $83 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,746 | $1,016 | $1,359 | $1,276 |
| End Cash | $2,273 | $2,746 | $1,016 | $1,359 |
| Free Cash Flow | -$418 | -$1,236 | -$3,301 | -$3,872 |